Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Protac pan-AKT degrader (ipatasertib-lenalidomide conjugate) | 2503017-97-6 | 99.7% | 798.41 g·mol⁻¹ | C44H56ClN7O5 | 5 MG
SDP

Supplier:  Medchemexpress LLC HY1331205MG

Encompass_Preferred

A potent, selective PROTAC-based pan-AKT degrader that links an ATP-competitive AKT inhibitor to a cereblon ligand to induce degradation of AKT1, AKT2, and AKT3. It is supplied as a white to off-white solid for research use in biochemical and cellular studies of AKT signaling and degradation mechanisms.

  • Potent degradation of AKT isoforms with low-nanomolar activity.
  • High chemical purity (≈99.7%).
  • Molecular weight 798.41 g·mol⁻¹ and formula C44H56ClN7O5.
  • White to off-white solid form.
  • Storage: sealed, away from moisture; in solvent -80°C up to 6 months, -20°C up to 1 month.
  • Suitable for biochemical and cellular AKT pathway studies.

Catalog No. 50-002-62067


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.